Drug Trial Radar · NCT06251089
Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)
Last checked: Nov 20, 2026Latest source record: Aug 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Nov 15, 2023
Primary completion
Aug 5, 2024
Study completion Aug 5, 2024
Sponsor
- Lead sponsor
- Dentaid SLIndustry
- Sponsor type
- Industry
- Collaborators
- Methodex
- First posted
- Feb 9, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 65 years, up to 100 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, controlled clinical trial with two parallel groups in which 150 volunteers (75 per group) will receive either VITIS CPC Protect® mouthwash (Mouthwash with cetylpyridinium chloride (CPC) as an anti-plaque antiseptic at a concentration of 0.07%) or mouthwash without cetylpyridinium chloride, as control group Subjects included in the study will be followed for 90 days. Symptoms associated with vURTIs (viral upper respiratory tract infections) should be recorded, when they appear, to determine the existence of viral infections of the upper respiratory tract. Symptoms and adverse effects will be recorded when the episode occurs. The assignment as VURIs will be made by the investigator once the diaries have been completed, or during the symptoms if possible.
Conditions
- Viral Pharyngitis
Interventions
CPC mouthwashDrug
0.07% CPC mouthwash
PlaceboDrug
placebo of the CPC mouthwash
Primary outcomes
What the sponsor says the trial is designed to measure.
- occurrence of vURTI episodesTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
EAP Baix Llobregat
Barcelona, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.